Immunocore Holdings plc
IMCR · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $1,474,735 | $3,340,095 | $2,156,793 | $1,074,871 |
| - Cash | $455,731 | $442,626 | $332,539 | $237,886 |
| + Debt | $432,722 | $84,032 | $69,303 | $63,836 |
| Enterprise Value | $1,451,726 | $2,981,501 | $1,893,557 | $900,821 |
| Revenue | $247,771 | $249,428 | $144,235 | $36,484 |
| % Growth | -0.7% | 72.9% | 295.3% | – |
| Gross Profit | $239,382 | $248,391 | $138,941 | $36,484 |
| % Margin | 96.6% | 99.6% | 96.3% | 100% |
| EBITDA | -$38,504 | -$51,646 | -$38,355 | -$166,715 |
| % Margin | -15.5% | -20.7% | -26.6% | -457% |
| Net Income | -$40,805 | -$55,287 | -$43,465 | -$180,029 |
| % Margin | -16.5% | -22.2% | -30.1% | -493.4% |
| EPS Diluted | -1.02 | -1.13 | -0.95 | -3 |
| % Growth | 9.7% | -18.9% | 68.3% | – |
| Operating Cash Flow | $26,061 | $2,940 | -$49,209 | -$143,106 |
| Capital Expenditures | -$5,173 | -$5,425 | -$2,203 | -$1,386 |
| Free Cash Flow | $20,888 | -$2,485 | -$51,412 | -$144,492 |